GLP-1 drug

The episode explores various topics including how weight loss surgery may treat childhood obesity and why the GLP-1 drug might influence restaurants to offer smaller portions. Additionally, it covers climate-friendly building materials researched by Penn researchers and reports on the unearthing of America's botanical roots as part of WHYY News’ America 250 coverage.

The VA is launching a trial of a GLP-1 drug to treat alcohol abuse, aiming to enroll over 600 veterans at 18 VA medical centers.

Rosie O’Donnell credits a GLP-1 drug with saving her life and has openly discussed her weight loss journey using the medication.

Rosie O’Donnell credits a GLP-1 drug for 'saving' her life and expresses a desire to do commercials promoting it. She has been open about her weight loss journey using GLP-1 medications.

Jenny Mollen described severe side effects, including 'blood everywhere,' from microdosing Tirzepatide, a GLP-1 drug typically used for diabetes, while taking a cocktail of peptides.

Research indicates the GLP-1 drug tirzepatide may enhance brown fat activity, which could increase calorie burning in the body. This effect occurs alongside appetite suppression, potentially offering additional weight management benefits.

Novo Nordisk's Wegovy weight loss pill has reached 3 million U.S. prescriptions, with over 80% of new prescriptions issued to patients who had never previously taken a GLP-1 drug.

Mayim Bialik described experiencing severe 'explosive' side effects from a GLP-1 drug, calling the reaction a 'nightmare.' The 'Blossom' alum stated that the adverse effects were more intense than implied by standard terminology.

Mayim Bialik described experiencing severe side effects from a GLP-1 drug, calling the reaction a 'nightmare.' She stated that an adverse reaction was 'somewhat of an understatement.'